Advertisement
Soliris
Specialty Drug

Eculizumab

ECULIZUMAB is a monoclonal antibody. It is used to treat a rare kind of anemia called paroxysmal nocturnal hemoglobinuria or PNH. It may help prevent the loss of blood in patients with PNH. Compare complement inhibitors.
Advertisement

Soliris Latest News

Get the latest updates on this drug from the GoodRx medical team

Recall: Soliris

Elizabeth Davis - June 09, 2014

Alexion Pharmaceuticals has announced a voluntary recall for several lots of Soliris (eculizumab) due to visible particles in the 300 mg/30 mL (10 mg/mL) concentrated solution for intravenous infusion.

Soliris is a specialty drug use to treat two rare conditions: paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

The particles have only been found in one lot, 10007A, however, Alexion is including several other lots where the vials were filled with the same components. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.